Claude Maraoui
Patrimonio netto: 15 M $ in data 31/05/2026
Patrimonio netto: 15 M $ in data 31/05/2026
Mr. Claude Maraoui is a President, Chief Executive Officer & Director at Journey Medical Corp.
and a Member at American Academy of Dermatology.
He is on the Board of Directors at Journey Medical Corp.
Mr. Maraoui was previously employed as a Vice President-Dermatology Sales by Medicis Pharmaceutical Corp.
He received his undergraduate degree from Rutgers State University of New Jersey.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
JOURNEY MEDICAL CORP. 11,31% | 22/04/2026 | 2.435.990 ( 11,31% ) | 15 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| JOURNEY MEDICAL CORPORATION | Fondatore | 01/10/2014 |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| MEDICIS PHARMACEUTICAL CORP | Corporate Officer/Principal | 01/04/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Commercial Services |
Journey Medical Corp.
Journey Medical Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for the treatment of dermatological treatment conditions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale